In the U.S., prostate cancer is the second leading cause of cancer-related death in men. Prostate cancer represents 30% of all cancers among Black men, and 15% of cancer-related deaths. Unfortunately, Black men are twice as likely to die of prostate cancer compared to White males. Dr. Dara’s talk will focus on Pfizer’s multicultural and health equity initiatives, their efforts to address cancer disparities and encourage screening and early cancer detection, and their commitment to diversity in clinical trial participation. Dr. Richardson-Heron’s talk will be followed by a panel discussion on prostate cancer disparities in Black men, featuring Dr. Rick Kittles of City of Hope’s Comprehensive Cancer Center and Mark Kennedy of Boston Public Health Commission’s Department of Population Sciences.